BioNTech SE: xbrl:AdjustmentsForFinanceCosts
| Value | {"unit": "EUR", "value": 20336000} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | superseded |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/a411631f-a25b-4274-8746-df7fba64c345
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-016723Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/a411631f-a25b-4274-8746-df7fba64c345
History
- no predecessors — first report